Squire Patton Boggs has advised Sydney-based AHP Group Limited (AHP) on its listing on the official list of the Sydney Stock Exchange (SSX).
AHP is an Australian-owned health product group, which focuses on the research, manufacture and sale of natural health and lifestyle products. AHP works with a number of biotechnology groups that drive biotechnical, pharmaceutical and medicinal research and development to deliver a unique range of premium health products and services.
The SSX, like the ASX, is an ASIC-regulated licensed stock exchange providing a platform for small-to-medium enterprises to enter the regulated market and receive the benefits enjoyed by publicly listed entities. The SSX represents a fast path for growth for emerging market applicants and a flexible entry-level alternative to the ASX market.
Squire Patton Boggs Perth managing partner Tony Chong led the transaction, along with associate Josh Walsh.
Tony Chong said: “We are all thrilled to have assisted AHP with their successful listing and we look forward to following their journey on the up-and-coming SSX.”
AHP listed on the SSX on 26 February 2021 and its market announcements page can be found at www.ssx.sydney/en/investors/securities/official-list/.